190.73MMarket Cap-663P/E (TTM)
0.970High0.860Low10.79MVolume0.880Open0.857Pre Close9.79MTurnover6.31%Turnover RatioLossP/E (Static)208.22MShares1.48052wk High8.04P/B156.59MFloat Cap0.29152wk Low--Dividend TTM170.95MShs Float51.375Historical High--Div YieldTTM12.84%Amplitude0.291Historical Low0.906Avg Price1Lot Size
Sangamo Therapeutics Stock Forum
0.9900.981
+28.95%
-0.92%
Sangamo Enters License Agreement With Genentech To Develop Intravenously Administered Genomic Medicines For Neurodegenerative Diseases; Co. Expected To Receive $50M In Near-Term Upfront License Fees And Is Eligible For Up To $1.9B In Milestones
尘埃落定,既成事实,这样的话,投资者们也就放心了。
still confuse about this waterfall
blowing out my mine
No comment yet